Use of levosimendan for treatment of cardiogenic shock associated with electrical storm

Annals of Internal Medicine

Volumn 150, Issue 10, 2009, Pages 738-740

  Grazi, Marco ^a   Lauri, Gianfranco ^a   Carbucicchio, Corrado ^a   Marenzi, Giancarlo ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOSIMENDAN; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

ADULT; ANURIA; CARDIOGENIC SHOCK; CASE REPORT; CATHETER ABLATION; DEFIBRILLATOR; DRUG INFUSION; HEART ATRIUM PRESSURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOTENSION; LABORATORY TEST; LETTER; LUNG DISEASE; MALE; METABOLIC ACIDOSIS; PRIORITY JOURNAL; MIDDLE AGED;

CARDIOTONIC AGENTS; DEFIBRILLATORS, IMPLANTABLE; HUMANS; HYDRAZONES; MALE; MIDDLE AGED; PYRIDAZINES; SHOCK, CARDIOGENIC; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 66149173642     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-150-10-200905190-00024     Document Type: Letter

References (4)

1. Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G, et al. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study. Circulation. 2008;117:462-469 [PMID: 18172038]
2. Petersen JW, Felker GM. Inotropes in the management of acute heart failure. Crit Care Med. 2008;36:S106-11. [PMID: 18158469]
3. Earl GL, Fitzpatrick JT. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure. Ann Pharmacother. 2005;39:1888-1896 [PMID: 16219899]
4. Lilleberg J, Ylönen V, Lehtonen L, Toivonen L. The calcium sensitizer levosimendan and cardiac arrhythmias: an analysis of the safety database of heart failure treatment studies. Scand Cardiovasc J. 2004;38:80-84 [PMID: 15204232] (Pubitemid 38659724)